Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel Free CVRX Stock Alerts

CVRx (CVRX) Financials

CVRx logo
$2.37 -0.02 (-0.84%)
As of 04:00 PM Eastern
Compare
Annual Income Statements for CVRx

Annual Income Statements for CVRx

This table shows CVRx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -41 -41 -60
Consolidated Net Income / (Loss)		 -41 -41 -60
Net Income / (Loss) Continuing Operations		 -41 -41 -60
Total Pre-Tax Income 		-41 -41 -60
Total Operating Income		 -43 -43 -59
Total Gross Profit		 17 33 43
Total Revenue		 22 39 51
Operating Revenue		 22 39 51
Total Cost of Revenue		 5.00 6.26 8.33
Operating Cost of Revenue		 5.00 6.26 8.33
Total Operating Expenses		 60 76 102
Selling, General & Admin Expense		 50 65 91
Research & Development Expense		 9.95 12 11
Total Other Income / (Expense), net		 1.21 2.05 -0.42
Interest Expense		 0.17 1.80 4.40
Other Income / (Expense), net		 1.37 3.85 3.98
Income Tax Expense		 0.11 0.15 0.06
Basic Earnings per Share		 ($2.02) ($1.99) ($2.65)
Weighted Average Basic Shares Outstanding		 20.53M 20.75M 22.60M
Diluted Earnings per Share		 ($2.02) ($1.99) ($2.65)
Weighted Average Diluted Shares Outstanding		 20.53M 20.75M 22.60M
Weighted Average Basic & Diluted Shares Outstanding		 20.69M 20.93M 26.04M

Quarterly Income Statements for CVRx

This table shows CVRx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q2 2026
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -9.83 -11 -11 -12 -9.01 -9.16 -22 -14 -13 -11 -14
Consolidated Net Income / (Loss)		 -9.83 -11 -11 -12 -9.01 -9.16 -22 -14 -13 -11 -14
Net Income / (Loss) Continuing Operations		 -9.83 -11 -11 -12 -9.01 -9.16 -22 -14 -13 -11 -14
Total Pre-Tax Income 		-9.80 -11 -11 -12 -8.97 -9.12 -22 -14 -13 -11 -14
Total Operating Income		 -10 -11 -12 -12 -9.53 -9.66 -22 -14 -13 -10 -13
Total Gross Profit		 4.85 5.67 6.65 7.98 8.82 9.59 9.16 9.91 11 13 14
Total Revenue		 6.19 7.18 7.98 9.50 11 11 11 12 13 15 16
Operating Revenue		 6.19 7.18 7.98 9.50 11 11 11 12 13 15 16
Total Cost of Revenue		 1.34 1.51 1.33 1.52 1.69 1.72 1.62 1.90 2.25 2.57 1.98
Operating Cost of Revenue		 1.34 1.51 1.33 1.52 1.69 1.72 1.62 1.90 2.25 2.57 1.98
Total Operating Expenses		 15 17 19 20 18 19 31 24 24 23 27
Selling, General & Admin Expense		 13 14 15 16 16 17 28 21 22 20 24
Research & Development Expense		 2.29 3.05 3.42 3.28 2.70 2.24 3.06 2.77 2.50 2.81 3.13
Total Other Income / (Expense), net		 0.33 0.97 0.82 0.14 0.56 0.54 0.08 -0.02 -0.04 -0.45 -1.02
Interest Expense		 0.00 0.17 0.24 0.48 0.50 0.58 0.96 0.96 0.96 1.52 1.58
Other Income / (Expense), net		 0.33 1.14 1.06 0.62 1.06 1.12 1.04 0.94 0.92 1.07 0.56
Income Tax Expense		 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.05 -0.07 0.00
Basic Earnings per Share		 ($0.48) ($0.51) ($0.55) ($0.56) ($0.43) ($0.45) ($1.04) ($0.65) ($0.57) ($0.39) ($0.53)
Weighted Average Basic Shares Outstanding		 20.58M 20.53M 20.69M 20.71M 20.80M 20.75M 21.23M 21.63M 22.78M 22.60M 26.52M
Diluted Earnings per Share		 ($0.48) ($0.51) ($0.55) ($0.56) ($0.43) ($0.45) ($1.04) ($0.65) ($0.57) ($0.39) ($0.53)
Weighted Average Diluted Shares Outstanding		 20.58M 20.53M 20.69M 20.71M 20.80M 20.75M 21.23M 21.63M 22.78M 22.60M 26.52M
Weighted Average Basic & Diluted Shares Outstanding		 20.58M 20.69M 20.71M 20.76M 20.82M 20.93M 21.60M 21.79M 24.26M 26.04M 26.64M

Annual Cash Flow Statements for CVRx

This table details how cash moves in and out of CVRx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -36 -16 15
Net Cash From Operating Activities		 -43 -39 -39
Net Cash From Continuing Operating Activities		 -43 -39 -39
Net Income / (Loss) Continuing Operations		 -41 -41 -60
Consolidated Net Income / (Loss)		 -41 -41 -60
Depreciation Expense		 0.41 0.52 0.62
Amortization Expense		 0.03 0.15 0.20
Non-Cash Adjustments To Reconcile Net Income		 3.89 6.31 19
Changes in Operating Assets and Liabilities, net		 -5.57 -4.81 0.95
Net Cash From Investing Activities		 -0.69 -0.59 -1.36
Net Cash From Continuing Investing Activities		 -0.69 -0.59 -1.36
Purchase of Property, Plant & Equipment		 -0.69 -0.59 -1.36
Net Cash From Financing Activities		 7.49 24 56
Net Cash From Continuing Financing Activities		 7.49 24 56
Repayment of Debt		 -0.78 -0.18 -0.15
Issuance of Debt		 7.50 23 20
Issuance of Common Equity		 0.59 0.94 33
Other Financing Activities, net		 0.18 0.73 2.70
Effect of Exchange Rate Changes		 -0.01 0.00 -0.00
Cash Interest Paid		 0.06 1.40 3.61

Quarterly Cash Flow Statements for CVRx

This table details how cash moves in and out of CVRx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q2 2026
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 6/30/2026
Net Change in Cash & Equivalents		 -11 -3.79 -2.92 -12 -7.82 7.58 -10 -9.72 30 5.77 -7.72
Net Cash From Operating Activities		 -11 -11 -10 -13 -8.13 -7.84 -11 -9.83 -10 -8.01 -8.83
Net Cash From Continuing Operating Activities		 -11 -11 -10 -13 -8.13 -7.84 -11 -9.83 -10 -8.01 -8.83
Net Income / (Loss) Continuing Operations		 -9.83 -11 -11 -12 -9.01 -9.16 -22 -14 -13 -11 -14
Consolidated Net Income / (Loss)		 -9.83 -11 -11 -12 -9.01 -9.16 -22 -14 -13 -11 -14
Depreciation Expense		 0.13 0.13 0.13 0.13 0.14 0.13 0.13 0.14 0.17 0.18 0.21
Amortization Expense		 - 0.03 0.03 0.04 0.04 0.04 0.05 0.05 0.05 0.06 0.08
Non-Cash Adjustments To Reconcile Net Income		 0.93 1.07 1.71 1.48 1.53 1.59 11 2.54 2.68 2.69 3.67
Changes in Operating Assets and Liabilities, net		 -2.32 -1.52 -0.74 -2.80 -0.82 -0.44 -0.03 1.47 -0.21 -0.28 1.26
Net Cash From Investing Activities		 -0.26 -0.08 -0.24 -0.14 -0.04 -0.17 -0.92 -0.36 -0.04 -0.05 -0.11
Net Cash From Continuing Investing Activities		 -0.26 -0.08 -0.24 -0.14 -0.04 -0.17 -0.92 -0.36 -0.04 -0.05 -0.11
Purchase of Property, Plant & Equipment		 -0.26 -0.08 -0.24 -0.14 -0.04 -0.17 -0.92 -0.36 -0.04 -0.05 -0.11
Net Cash From Financing Activities		 0.01 7.12 7.57 0.47 0.36 16 1.36 0.47 40 14 1.22
Net Cash From Continuing Financing Activities		 0.01 7.12 7.57 0.47 0.36 16 1.36 0.47 40 14 1.22
Repayment of Debt		 - -0.78 -0.06 -0.01 - -0.11 - - -0.15 -0.00 -0.00
Issuance of Common Equity		 - 0.29 0.00 0.45 - 0.48 0.55 0.41 20 13 1.19
Other Financing Activities, net		 0.01 0.10 0.13 0.03 0.36 0.21 0.82 0.07 0.73 1.09 0.04
Cash Interest Paid		 - 0.06 0.19 0.38 0.42 0.42 0.77 0.84 0.84 1.16 1.42

Annual Balance Sheets for CVRx

This table presents CVRx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 125 115 133
Total Current Assets		 123 112 130
Cash & Equivalents		 106 91 106
Accounts Receivable		 5.50 7.55 9.27
Inventories, net		 6.96 11 12
Prepaid Expenses		 4.22 2.99 2.51
Plant, Property, & Equipment, net		 1.70 1.76 2.51
Total Noncurrent Assets		 0.36 1.38 1.10
Other Noncurrent Operating Assets		 0.36 1.38 1.10
Total Liabilities & Shareholders' Equity		 125 115 133
Total Liabilities		 16 39 62
Total Current Liabilities		 8.09 7.86 11
Accounts Payable		 1.72 1.88 2.58
Accrued Expenses		 6.37 5.98 8.18
Total Noncurrent Liabilities		 7.67 31 52
Long-Term Debt		 6.75 29 49
Other Noncurrent Operating Liabilities		 0.92 2.20 2.32
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 109 76 71
Total Preferred & Common Equity		 109 76 71
Total Common Equity		 109 76 71
Common Stock		 546 554 609
Retained Earnings		 -436 -477 -537
Accumulated Other Comprehensive Income / (Loss)		 -0.21 -0.21 -0.21

Quarterly Balance Sheets for CVRx

This table presents CVRx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q2 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 6/30/2026
Total Assets		 127 123 115 106 106 96 128 92
Total Current Assets		 124 121 112 104 102 92 124 89
Cash & Equivalents		 110 103 91 83 80 70 100 65
Accounts Receivable		 5.30 6.43 6.73 6.37 8.50 8.61 9.03 9.40
Inventories, net		 6.06 8.24 11 11 11 11 12 13
Prepaid Expenses		 3.07 2.63 3.54 3.35 2.66 1.76 2.79 2.47
Plant, Property, & Equipment, net		 1.75 1.81 1.82 1.72 2.55 2.76 2.63 2.06
Total Noncurrent Assets		 0.42 0.30 1.14 1.08 1.30 1.23 1.17 0.73
Other Noncurrent Operating Assets		 0.42 0.30 1.14 1.08 1.30 1.23 1.17 0.73
Total Liabilities & Shareholders' Equity		 127 123 115 106 106 96 128 92
Total Liabilities		 8.33 23 25 24 40 41 62 72
Total Current Liabilities		 7.40 7.96 8.93 7.41 8.40 9.13 11 11
Accounts Payable		 1.28 2.00 2.93 1.13 2.61 3.52 3.28 3.87
Accrued Expenses		 6.12 5.96 5.99 6.27 5.79 5.61 7.67 7.25
Total Noncurrent Liabilities		 0.94 15 16 16 32 32 52 61
Long-Term Debt		 - 14 14 14 29 29 49 59
Other Noncurrent Operating Liabilities		 0.94 0.87 1.83 1.88 2.24 2.29 2.33 2.64
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 118 100 90 83 66 55 65 20
Total Preferred & Common Equity		 118 100 90 83 66 55 65 20
Total Common Equity		 118 100 90 83 66 55 65 20
Common Stock		 544 547 549 551 566 569 592 638
Retained Earnings		 -426 -448 -459 -468 -500 -514 -527 -618
Accumulated Other Comprehensive Income / (Loss)		 -0.22 -0.20 -0.19 -0.21 -0.21 -0.21 -0.21 -0.20

Annual Metrics And Ratios for CVRx

This table displays calculated financial ratios and metrics derived from CVRx's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 72.36% 74.89% 30.53%
EBITDA Growth		 -0.86% 5.26% -41.77%
EBIT Growth		 -0.95% 4.62% -41.42%
NOPAT Growth		 -63.77% -1.35% -38.02%
Net Income Growth		 3.83% 0.55% -45.55%
EPS Growth		 51.44% 1.49% -33.17%
Operating Cash Flow Growth		 -53.89% 8.57% -0.32%
Free Cash Flow Firm Growth		 -41.59% 1.62% -18.26%
Invested Capital Growth		 150.40% 50.01% -1.40%
Revenue Q/Q Growth		 18.56% 11.74% 8.54%
EBITDA Q/Q Growth		 -0.30% 4.49% -1.08%
EBIT Q/Q Growth		 -0.47% 4.38% -1.20%
NOPAT Q/Q Growth		 -6.76% 4.05% -1.04%
Net Income Q/Q Growth		 0.08% 3.23% -2.54%
EPS Q/Q Growth		 -103.01% 2.93% 2.21%
Operating Cash Flow Q/Q Growth		 -9.85% 7.14% -0.43%
Free Cash Flow Firm Q/Q Growth		 0.00% 6.10% -0.28%
Invested Capital Q/Q Growth		 17.85% 3.34% 1.12%
Profitability Metrics		 - - -
Gross Margin		 77.75% 84.08% 83.75%
EBITDA Margin		 -181.21% -98.17% -106.63%
Operating Margin		 -189.27% -109.69% -115.98%
EBIT Margin		 -183.16% -99.89% -108.23%
Profit (Net Income) Margin		 -184.38% -104.85% -116.91%
Tax Burden Percent		 100.26% 100.36% 100.09%
Interest Burden Percent		 100.40% 104.58% 107.92%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -437.14% -247.99% -287.24%
ROIC Less NNEP Spread (ROIC-NNEP)		 -427.48% -234.28% -256.19%
Return on Net Nonoperating Assets (RNNOA)		 404.66% 203.48% 205.66%
Return on Equity (ROE)		 -32.47% -44.51% -81.58%
Cash Return on Invested Capital (CROIC)		 -522.98% -288.00% -285.83%
Operating Return on Assets (OROA)		 -29.66% -32.69% -44.65%
Return on Assets (ROA)		 -29.86% -34.31% -48.23%
Return on Common Equity (ROCE)		 -32.47% -44.51% -81.58%
Return on Equity Simple (ROE_SIMPLE)		 -37.94% -54.25% -84.39%
Net Operating Profit after Tax (NOPAT)		 -30 -30 -42
NOPAT Margin		 -132.49% -76.78% -81.19%
Net Nonoperating Expense Percent (NNEP)		 -9.65% -13.72% -31.05%
Return On Investment Capital (ROIC_SIMPLE)		 - -28.69% -34.61%
Cost of Revenue to Revenue		 22.25% 15.92% 16.25%
SG&A Expenses to Revenue		 222.73% 164.17% 178.03%
R&D to Revenue		 44.29% 29.60% 21.70%
Operating Expenses to Revenue		 267.02% 193.77% 199.73%
Earnings before Interest and Taxes (EBIT)		 -41 -39 -56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -41 -39 -55
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 3.46 8.62 4.33
Price to Tangible Book Value (P/TBV)		 3.46 8.62 4.33
Price to Revenue (P/Rev)		 16.81 16.65 5.99
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 28.59 40.62 17.42
Enterprise Value to Revenue (EV/Rev)		 12.38 15.09 4.89
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.06 0.38 0.69
Long-Term Debt to Equity		 0.06 0.38 0.69
Financial Leverage		 -0.95 -0.87 -0.80
Leverage Ratio		 1.09 1.30 1.69
Compound Leverage Factor		 1.09 1.36 1.83
Debt to Total Capital		 5.82% 27.79% 40.95%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 5.82% 27.79% 40.95%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 94.18% 72.21% 59.05%
Debt to EBITDA		 -0.17 -0.76 -0.90
Net Debt to EBITDA		 2.44 1.59 1.04
Long-Term Debt to EBITDA		 -0.17 -0.76 -0.90
Debt to NOPAT		 -0.23 -0.97 -1.18
Net Debt to NOPAT		 3.34 2.03 1.36
Long-Term Debt to NOPAT		 -0.23 -0.97 -1.18
Altman Z-Score		 9.69 4.50 -2.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 15.19 14.25 12.06
Quick Ratio		 13.81 12.48 10.70
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 -36 -35 -41
Operating Cash Flow to CapEx		 -6,230.22% -6,602.54% -2,876.12%
Free Cash Flow to Firm to Interest Expense		 -215.85 -19.48 -9.42
Operating Cash Flow to Interest Expense		 -258.65 -21.69 -8.90
Operating Cash Flow Less CapEx to Interest Expense		 -262.80 -22.02 -9.21
Efficiency Ratios		 - - -
Asset Turnover		 0.16 0.33 0.41
Accounts Receivable Turnover		 5.57 6.02 6.10
Inventory Turnover		 0.92 0.70 0.72
Fixed Asset Turnover		 14.39 22.71 24.04
Accounts Payable Turnover		 4.49 3.47 3.73
Days Sales Outstanding (DSO)		 65.50 60.63 59.84
Days Inventory Outstanding (DIO)		 395.63 523.35 505.63
Days Payable Outstanding (DPO)		 81.37 105.11 97.80
Cash Conversion Cycle (CCC)		 379.75 478.87 467.68
Capital & Investment Metrics		 - - -
Invested Capital		 9.73 15 14
Invested Capital Turnover		 3.30 3.23 3.54
Increase / (Decrease) in Invested Capital		 5.85 4.87 -0.21
Enterprise Value (EV)		 278 593 251
Market Capitalization		 378 654 307
Book Value per Share		 $5.30 $3.65 $2.93
Tangible Book Value per Share		 $5.30 $3.65 $2.93
Total Capital		 116 105 120
Total Debt		 6.75 29 49
Total Long-Term Debt		 6.75 29 49
Net Debt		 -99 -61 -57
Capital Expenditures (CapEx)		 0.69 0.59 1.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 8.60 14 13
Debt-free Net Working Capital (DFNWC)		 115 104 119
Net Working Capital (NWC)		 115 104 119
Net Nonoperating Expense (NNE)		 12 11 18
Net Nonoperating Obligations (NNO)		 -99 -61 -57
Total Depreciation and Amortization (D&A)		 0.44 0.68 0.82
Debt-free, Cash-free Net Working Capital to Revenue		 38.26% 34.76% 25.58%
Debt-free Net Working Capital to Revenue		 510.88% 265.24% 232.10%
Net Working Capital to Revenue		 510.88% 265.24% 232.10%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 ($2.02) ($1.99) ($2.65)
Adjusted Weighted Average Basic Shares Outstanding		 20.53M 20.75M 22.60M
Adjusted Diluted Earnings per Share		 ($2.02) ($1.99) ($2.65)
Adjusted Weighted Average Diluted Shares Outstanding		 20.53M 20.75M 22.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 20.69M 20.93M 26.04M
Normalized Net Operating Profit after Tax (NOPAT)		 -30 -30 -42
Normalized NOPAT Margin		 -132.49% -76.78% -81.19%
Pre Tax Income Margin		 -183.89% -104.47% -116.80%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 -249.42 -21.82 -12.63
NOPAT to Interest Expense		 -180.42 -16.77 -9.47
EBIT Less CapEx to Interest Expense		 -253.57 -22.15 -12.93
NOPAT Less CapEx to Interest Expense		 -184.57 -17.10 -9.78
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for CVRx

This table displays calculated financial ratios and metrics derived from CVRx's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q2 2026
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - - 26,535,944.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 26,535,944.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.53
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 82.21% 96.17% 95.76% 88.83% 69.92% 57.54% 34.98% 24.28% 27.23% 35.71% 15.57%
EBITDA Growth		 -79.59% -1.19% -10.47% -0.13% 14.24% 17.80% -92.04% -17.07% -43.24% -7.01% 6.48%
EBIT Growth		 -78.28% -1.91% -11.39% -0.80% 13.53% 17.38% -90.88% -17.00% -42.75% -7.69% 6.05%
NOPAT Growth		 -38.88% -30.62% -22.75% -6.70% 5.91% 15.84% -82.80% -18.90% -36.56% -6.35% 9.41%
Net Income Growth		 -60.28% 0.32% -13.84% -5.24% 8.33% 13.03% -95.06% -20.41% -45.37% -16.24% 4.70%
EPS Growth		 -60.00% -100.74% -12.24% -3.70% 10.42% 11.76% -89.09% -16.07% -32.56% 13.33% 7.02%
Operating Cash Flow Growth		 -20.41% -54.54% 3.71% -26.86% 26.78% 27.69% -6.31% 23.25% -28.12% -2.16% -11.21%
Free Cash Flow Firm Growth		 -16.67% 0.00% -7.24% 47.54% -13.86% 16.22% -51.39% 33.37% 26.50% 39.92% -31.18%
Invested Capital Growth		 90.52% 150.40% 88.13% 131.07% 71.06% 50.01% 45.65% 5.71% 0.76% -1.40% 13.31%
Revenue Q/Q Growth		 22.96% 16.00% 11.19% 19.06% 10.64% 7.55% -4.73% 9.63% 13.26% 14.72% 6.34%
EBITDA Q/Q Growth		 11.70% -5.37% -7.36% -0.25% 24.37% -0.99% -150.82% 38.89% 7.47% 24.55% -7.89%
EBIT Q/Q Growth		 11.31% -5.56% -7.32% -0.32% 23.92% -0.86% -147.96% 38.51% 7.18% 23.91% -7.74%
NOPAT Q/Q Growth		 8.06% -13.36% -5.95% 3.37% 18.92% -1.40% -130.12% 37.15% 6.88% 21.04% -7.09%
Net Income Q/Q Growth		 11.21% -7.18% -7.95% -2.44% 22.66% -1.69% -142.13% 36.77% 6.63% 18.69% -7.04%
EPS Q/Q Growth		 11.11% -6.25% -7.84% -1.82% 23.21% -4.65% -131.11% 37.50% 12.31% 31.58% -6.00%
Operating Cash Flow Q/Q Growth		 -9.90% 2.30% 5.46% -24.97% 36.56% 3.52% -39.00% 9.78% -5.90% 23.07% 27.44%
Free Cash Flow Firm Q/Q Growth		 63.50% -26.05% 2.95% -17.50% 20.78% 7.25% -75.36% 48.29% 12.62% 24.19% -38.13%
Invested Capital Q/Q Growth		 42.40% 17.85% 8.74% 26.63% 5.42% 3.34% 5.59% -8.10% 0.49% 1.12% -8.88%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 78.34% 78.97% 83.36% 84.03% 83.91% 84.79% 85.00% 83.91% 83.19% 83.24% 87.39%
EBITDA Margin		 -156.34% -142.00% -137.11% -115.44% -78.91% -74.09% -195.07% -108.74% -88.84% -58.42% -77.49%
Operating Margin		 -163.69% -159.96% -152.43% -123.71% -90.65% -85.46% -206.43% -118.35% -97.29% -66.97% -82.92%
EBIT Margin		 -158.39% -144.13% -139.12% -117.22% -80.60% -75.59% -196.73% -110.35% -90.44% -59.98% -79.36%
Profit (Net Income) Margin		 -158.91% -146.82% -142.55% -122.64% -85.73% -81.05% -206.00% -118.82% -97.95% -69.42% -89.42%
Tax Burden Percent		 100.33% 100.27% 100.30% 100.29% 100.45% 100.43% 100.17% 100.29% 100.36% 99.34% 100.02%
Interest Burden Percent		 100.00% 101.60% 102.16% 104.32% 105.89% 106.78% 104.53% 107.36% 107.92% 116.52% 112.66%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -344.85% -369.45% -347.17% -278.16% -199.35% -193.21% -467.79% -266.79% -226.93% -165.85% -270.72%
ROIC Less NNEP Spread (ROIC-NNEP)		 -342.75% -367.38% -344.57% -274.70% -196.73% -190.22% -458.33% -259.57% -220.26% -159.99% -251.64%
Return on Net Nonoperating Assets (RNNOA)		 326.99% 347.77% 320.95% 250.41% 174.82% 165.22% 386.50% 210.29% 178.05% 128.43% 166.86%
Return on Equity (ROE)		 -17.85% -21.68% -26.22% -27.76% -24.52% -27.99% -81.30% -56.50% -48.88% -37.42% -103.86%
Cash Return on Invested Capital (CROIC)		 0.00% -522.98% -447.93% -411.05% -333.35% -288.00% -323.49% -286.85% -291.37% -285.83% -271.98%
Operating Return on Assets (OROA)		 -19.47% -23.34% -27.47% -29.04% -24.33% -24.73% -72.35% -46.44% -36.51% -24.75% -45.84%
Return on Assets (ROA)		 -19.54% -23.78% -28.15% -30.38% -25.88% -26.52% -75.76% -50.01% -39.55% -28.64% -51.66%
Return on Common Equity (ROCE)		 -17.85% -21.68% -26.22% -27.76% -24.52% -27.99% -81.30% -56.50% -48.88% -37.42% -103.86%
Return on Equity Simple (ROE_SIMPLE)		 -35.06% 0.00% -42.96% -48.23% -51.40% 0.00% -78.49% -98.45% -89.71% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -7.09 -8.04 -8.51 -8.23 -6.67 -6.76 -16 -9.78 -9.11 -7.19 -9.12
NOPAT Margin		 -114.58% -111.97% -106.70% -86.59% -63.45% -59.82% -144.50% -82.84% -68.11% -46.88% -58.05%
Net Nonoperating Expense Percent (NNEP)		 -2.10% -2.07% -2.60% -3.46% -2.62% -2.99% -9.47% -7.22% -6.67% -5.86% -19.08%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -6.43% - - - -5.98% -11.61%
Cost of Revenue to Revenue		 21.66% 21.03% 16.64% 15.97% 16.09% 15.21% 15.00% 16.09% 16.81% 16.76% 12.61%
SG&A Expenses to Revenue		 204.96% 196.49% 192.97% 173.21% 148.91% 150.42% 263.05% 178.83% 161.76% 131.93% 150.38%
R&D to Revenue		 37.07% 42.45% 42.81% 34.53% 25.65% 19.82% 28.38% 23.42% 18.72% 18.28% 19.93%
Operating Expenses to Revenue		 242.03% 238.94% 235.78% 207.74% 174.56% 170.24% 291.43% 202.25% 180.48% 150.21% 170.31%
Earnings before Interest and Taxes (EBIT)		 -9.80 -10 -11 -11 -8.47 -8.55 -21 -13 -12 -9.20 -12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -9.67 -10 -11 -11 -8.29 -8.38 -21 -13 -12 -8.96 -12
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.62 3.46 1.94 3.55 3.80 8.62 5.72 4.69 2.94 4.33 6.84
Price to Tangible Book Value (P/TBV)		 1.62 3.46 1.94 3.55 3.80 8.62 5.72 4.69 2.94 4.33 6.84
Price to Revenue (P/Rev)		 10.13 16.81 7.31 10.37 8.95 16.65 9.01 5.83 4.06 5.99 2.23
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 9.93 28.59 9.81 18.15 17.42 40.62 21.29 15.38 9.90 17.42 9.35
Enterprise Value to Revenue (EV/Rev)		 4.33 12.38 3.94 7.89 7.00 15.09 7.80 4.91 2.98 4.89 2.13
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.06 0.14 0.16 0.17 0.38 0.44 0.53 0.76 0.69 2.94
Long-Term Debt to Equity		 0.00 0.06 0.14 0.16 0.17 0.38 0.44 0.53 0.76 0.69 2.94
Financial Leverage		 -0.95 -0.95 -0.93 -0.91 -0.89 -0.87 -0.84 -0.81 -0.81 -0.80 -0.66
Leverage Ratio		 1.13 1.09 1.13 1.15 1.16 1.30 1.38 1.45 1.58 1.69 2.72
Compound Leverage Factor		 1.13 1.10 1.15 1.20 1.23 1.39 1.44 1.56 1.71 1.97 3.06
Debt to Total Capital		 0.00% 5.82% 12.49% 13.68% 14.72% 27.79% 30.64% 34.67% 43.02% 40.95% 74.59%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 5.82% 12.49% 13.68% 14.72% 27.79% 30.64% 34.67% 43.02% 40.95% 74.59%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 94.18% 87.51% 86.32% 85.28% 72.21% 69.36% 65.33% 56.98% 59.05% 25.41%
Debt to EBITDA		 0.00 -0.17 -0.34 -0.34 -0.35 -0.76 -0.60 -0.58 -0.91 -0.90 -1.31
Net Debt to EBITDA		 0.00 2.44 2.13 1.83 1.70 1.59 1.05 0.81 0.94 1.04 0.13
Long-Term Debt to EBITDA		 0.00 -0.17 -0.34 -0.34 -0.35 -0.76 -0.60 -0.58 -0.91 -0.90 -1.31
Debt to NOPAT		 0.00 -0.23 -0.45 -0.45 -0.45 -0.97 -0.79 -0.76 -1.19 -1.18 -1.72
Net Debt to NOPAT		 0.00 3.34 2.84 2.40 2.18 2.03 1.37 1.06 1.24 1.36 0.18
Long-Term Debt to NOPAT		 0.00 -0.23 -0.45 -0.45 -0.45 -0.97 -0.79 -0.76 -1.19 -1.18 -1.72
Altman Z-Score		 10.12 10.50 0.93 3.10 3.01 5.38 -0.09 -2.63 -2.81 -1.45 -7.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 16.82 15.19 15.15 12.55 13.99 14.25 12.18 10.08 11.32 12.06 8.04
Quick Ratio		 15.59 13.81 13.79 10.93 12.06 12.48 10.55 8.66 9.97 10.70 6.65
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -11 -14 -13 -16 -13 -12 -20 -11 -9.22 -6.99 -11
Operating Cash Flow to CapEx		 -4,203.03% -13,722.78% -4,270.42% -8,956.64% -20,833.33% -4,638.46% -1,188.22% -2,769.01% -28,135.14% -15,400.00% -7,880.36%
Free Cash Flow to Firm to Interest Expense		 0.00 -84.13 -56.13 -32.91 -25.13 -20.09 -21.24 -11.00 -9.62 -4.60 -6.81
Operating Cash Flow to Interest Expense		 0.00 -65.70 -42.70 -26.63 -16.28 -13.54 -11.35 -10.25 -10.87 -5.27 -5.59
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -66.18 -43.70 -26.93 -16.36 -13.83 -12.31 -10.62 -10.91 -5.30 -5.66
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.12 0.16 0.20 0.25 0.30 0.33 0.37 0.42 0.40 0.41 0.58
Accounts Receivable Turnover		 4.35 5.57 5.22 5.97 6.03 6.02 5.64 5.79 6.14 6.10 7.39
Inventory Turnover		 0.94 0.92 0.80 0.68 0.71 0.70 0.68 0.63 0.66 0.72 0.65
Fixed Asset Turnover		 14.09 14.39 15.24 17.98 20.27 22.71 19.33 19.37 21.71 24.04 27.77
Accounts Payable Turnover		 4.92 4.49 2.99 3.22 5.02 3.47 2.84 2.15 3.39 3.73 2.32
Days Sales Outstanding (DSO)		 83.96 65.50 69.94 61.11 60.56 60.63 64.74 63.03 59.49 59.84 49.37
Days Inventory Outstanding (DIO)		 387.68 395.63 458.18 537.24 511.75 523.35 538.24 583.70 555.55 505.63 564.21
Days Payable Outstanding (DPO)		 74.12 81.37 122.27 113.49 72.73 105.11 128.42 169.93 107.53 97.80 157.44
Cash Conversion Cycle (CCC)		 397.52 379.75 405.86 484.86 499.58 478.87 474.56 476.80 507.51 467.68 456.14
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 8.26 9.73 11 13 14 15 15 14 14 14 14
Invested Capital Turnover		 3.01 3.30 3.25 3.21 3.14 3.23 3.24 3.22 3.33 3.54 4.66
Increase / (Decrease) in Invested Capital		 3.92 5.85 4.96 7.60 5.87 4.87 4.83 0.77 0.11 -0.21 1.64
Enterprise Value (EV)		 82 278 104 243 246 593 328 218 141 251 130
Market Capitalization		 192 378 193 320 315 654 379 259 192 307 136
Book Value per Share		 $5.75 $5.30 $4.82 $4.34 $3.99 $3.65 $3.12 $2.56 $2.99 $2.93 $0.75
Tangible Book Value per Share		 $5.75 $5.30 $4.82 $4.34 $3.99 $3.65 $3.12 $2.56 $2.99 $2.93 $0.75
Total Capital		 118 116 114 104 97 105 96 85 114 120 79
Total Debt		 0.00 6.75 14 14 14 29 29 29 49 49 59
Total Long-Term Debt		 0.00 6.75 14 14 14 29 29 29 49 49 59
Net Debt		 -110 -99 -89 -77 -69 -61 -51 -41 -51 -57 -6.02
Capital Expenditures (CapEx)		 0.26 0.08 0.24 0.14 0.04 0.17 0.92 0.36 0.04 0.05 0.11
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 7.03 8.60 9.35 12 13 14 14 12 13 13 14
Debt-free Net Working Capital (DFNWC)		 117 115 113 103 96 104 94 83 113 119 78
Net Working Capital (NWC)		 117 115 113 103 96 104 94 83 113 119 78
Net Nonoperating Expense (NNE)		 2.74 2.50 2.86 3.42 2.34 2.40 6.62 4.25 3.99 3.46 4.93
Net Nonoperating Obligations (NNO)		 -110 -99 -89 -77 -69 -61 -51 -41 -51 -57 -6.02
Total Depreciation and Amortization (D&A)		 0.13 0.15 0.16 0.17 0.18 0.17 0.18 0.19 0.21 0.24 0.29
Debt-free, Cash-free Net Working Capital to Revenue		 37.10% 38.26% 35.45% 39.79% 37.53% 34.76% 32.81% 28.08% 27.01% 25.58% 22.52%
Debt-free Net Working Capital to Revenue		 617.47% 510.88% 427.06% 334.25% 273.53% 265.24% 223.17% 186.66% 238.97% 232.10% 128.07%
Net Working Capital to Revenue		 617.47% 510.88% 427.06% 334.25% 273.53% 265.24% 223.17% 186.66% 238.97% 232.10% 128.07%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.48) ($0.51) ($0.55) ($0.56) ($0.43) ($0.45) ($1.04) ($0.65) ($0.57) ($0.39) ($0.53)
Adjusted Weighted Average Basic Shares Outstanding		 20.58M 20.53M 20.69M 20.71M 20.80M 20.75M 21.23M 21.63M 22.78M 22.60M 26.52M
Adjusted Diluted Earnings per Share		 ($0.48) ($0.51) ($0.55) ($0.56) ($0.43) ($0.45) ($1.04) ($0.65) ($0.57) ($0.39) ($0.53)
Adjusted Weighted Average Diluted Shares Outstanding		 20.58M 20.53M 20.69M 20.71M 20.80M 20.75M 21.23M 21.63M 22.78M 22.60M 26.52M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 20.58M 20.69M 20.71M 20.76M 20.82M 20.93M 21.60M 21.79M 24.26M 26.04M 26.64M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.09 -8.04 -8.51 -8.23 -6.67 -6.76 -16 -9.78 -9.11 -7.19 -9.12
Normalized NOPAT Margin		 -114.58% -111.97% -106.70% -86.59% -63.45% -59.82% -144.50% -82.84% -68.11% -46.88% -58.05%
Pre Tax Income Margin		 -158.39% -146.43% -142.12% -122.28% -85.35% -80.71% -205.65% -118.47% -97.60% -69.89% -89.40%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 -62.68 -46.25 -23.15 -16.98 -14.76 -22.07 -13.59 -12.62 -6.05 -7.90
NOPAT to Interest Expense		 0.00 -48.70 -35.47 -17.10 -13.37 -11.68 -16.21 -10.20 -9.51 -4.73 -5.78
EBIT Less CapEx to Interest Expense		 0.00 -63.16 -47.25 -23.45 -17.06 -15.05 -23.03 -13.96 -12.66 -6.09 -7.97
NOPAT Less CapEx to Interest Expense		 0.00 -49.18 -36.47 -17.40 -13.44 -11.97 -17.17 -10.57 -9.55 -4.77 -5.85
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

CVRx (NASDAQ: CVRX) continues to grow revenue, but profitability and cash burn remain the main issues. Over the last four years, the company has expanded its quarterly top line from roughly $8.0 million in Q1 2023 to $14.8 million in Q1 2026, yet it is still posting sizable operating losses and negative operating cash flow. The balance sheet shows a strong cash position, but that cushion has started to decline as operating losses continue.

  • Revenue has trended higher over time, rising from $7.98 million in Q1 2023 to $14.77 million in Q1 2026.
  • Gross profit improved materially in Q1 2026 to $12.88 million, with gross margin remaining strong at about 87%.
  • CVRx ended Q1 2026 with $72.3 million in cash and equivalents, which still provides a sizable liquidity buffer.
  • Long-term debt declined from $58.5 million at Q1 2026 from $49.4 million at Q3 2025? Wait—looking at the trend, debt has generally been managed without explosive growth, and the company paid down some debt in earlier quarters.
  • Non-cash charges continue to support reported losses in operating cash flow, which means the cash burn is less severe than the headline net loss suggests.
  • R&D spending has been fairly stable to slightly lower year over year in recent quarters, suggesting controlled investment rather than aggressive spending growth.
  • Shares outstanding have increased over the past year, but the pace of dilution appears moderate rather than extreme in the most recent quarters.
  • The company’s other income line has helped offset some interest expense, but not enough to reach profitability.
  • CVRx reported a Q1 2026 net loss of $13.12 million, nearly unchanged from losses in prior quarters.
  • Operating cash flow was negative $12.16 million in Q1 2026, and the company burned $3.4 million in cash during the quarter.
  • Selling, general and administrative expense remains very heavy at $21.96 million in Q1 2026, far above gross profit and the biggest reason the company remains unprofitable.

Quarterly trend commentary: Revenue has been moving up steadily, but expenses have also stayed elevated, especially SG&A. That has kept operating income deeply negative across the period reviewed. In Q1 2026, operating loss was $12.16 million versus $13.44 million in Q1 2025, so there was some improvement, but not enough to show a clear path to profitability yet.

Balance sheet and liquidity: CVRx’s current asset base remains meaningful, led by $72.3 million of cash and equivalents, $9.1 million of receivables, and $12.4 million of inventory. Total assets were $99.7 million, while total liabilities were $70.6 million, leaving equity of $29.1 million. The company is still funded for now, but the cash balance fell from $85.1 million in Q3 2025 to $72.3 million in Q1 2026, so investors should keep an eye on the burn rate.

Bottom line: CVRx is showing real revenue growth and solid gross margins, which is encouraging. But the company is still spending heavily to grow, and profitability remains distant. For retail investors, the key question is whether revenue growth can continue to outpace operating expenses before cash levels become more constrained.

08/10/26 10:38 PM ETAI Generated. May Contain Errors.

CVRx Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CVRx's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

CVRx's net income appears to be on an upward trend, with a most recent value of -$59.97 million in 2024, rising from -$41.43 million in 2022. The previous period was -$41.20 million in 2023. Check out CVRx's forecast to explore projected trends and price targets.

CVRx's total operating income in 2024 was -$59.49 million, based on the following breakdown:
  • Total Gross Profit: $42.96 million
  • Total Operating Expenses: $102.45 million

Over the last 2 years, CVRx's total revenue changed from $22.47 million in 2022 to $51.29 million in 2024, a change of 128.3%.

CVRx's total liabilities were at $62.36 million at the end of 2024, a 58.7% increase from 2023, and a 295.8% increase since 2022.

In the past 2 years, CVRx's cash and equivalents has ranged from $90.57 million in 2023 to $106.19 million in 2022, and is currently $105.93 million as of their latest financial filing in 2024.

Over the last 2 years, CVRx's book value per share changed from 5.30 in 2022 to 2.93 in 2024, a change of -44.8%.


Related Companies

Financial statements for NASDAQ:CVRX last updated on 7/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
$8B is moving in... are you?
Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...
Awesomely | Sponsoredtc pixel
Trump's Next Move Could Shrink Your Dollar
There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. d...
Priority Gold | Sponsoredtc pixel